EP3813687A4 - Compositions pharmaceutiques et procédés pour le traitement de la thrombose et l'administration par des dispositifs médicaux - Google Patents

Compositions pharmaceutiques et procédés pour le traitement de la thrombose et l'administration par des dispositifs médicaux Download PDF

Info

Publication number
EP3813687A4
EP3813687A4 EP19824845.2A EP19824845A EP3813687A4 EP 3813687 A4 EP3813687 A4 EP 3813687A4 EP 19824845 A EP19824845 A EP 19824845A EP 3813687 A4 EP3813687 A4 EP 3813687A4
Authority
EP
European Patent Office
Prior art keywords
thrombosis
delivery
treatment
methods
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19824845.2A
Other languages
German (de)
English (en)
Other versions
EP3813687A1 (fr
Inventor
Michael K. HANDLEY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marizyme Inc
Original Assignee
Marizyme Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marizyme Biotech filed Critical Marizyme Biotech
Publication of EP3813687A1 publication Critical patent/EP3813687A1/fr
Publication of EP3813687A4 publication Critical patent/EP3813687A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4806—Hydrolases (3) acting on peptide bonds (3.4) from animals other than mammals, e.g. snakes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21001—Chymotrypsin (3.4.21.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027—Type of occlusion
    • A61B17/12036—Type of occlusion partial occlusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027—Type of occlusion
    • A61B17/1204—Type of occlusion temporary occlusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136—Balloons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
EP19824845.2A 2018-06-28 2019-06-28 Compositions pharmaceutiques et procédés pour le traitement de la thrombose et l'administration par des dispositifs médicaux Withdrawn EP3813687A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862691319P 2018-06-28 2018-06-28
PCT/US2019/039878 WO2020006444A1 (fr) 2018-06-28 2019-06-28 Compositions pharmaceutiques et procédés pour le traitement de la thrombose et l'administration par des dispositifs médicaux

Publications (2)

Publication Number Publication Date
EP3813687A1 EP3813687A1 (fr) 2021-05-05
EP3813687A4 true EP3813687A4 (fr) 2022-03-23

Family

ID=68985200

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19824845.2A Withdrawn EP3813687A4 (fr) 2018-06-28 2019-06-28 Compositions pharmaceutiques et procédés pour le traitement de la thrombose et l'administration par des dispositifs médicaux

Country Status (9)

Country Link
EP (1) EP3813687A4 (fr)
JP (1) JP2022525713A (fr)
CN (1) CN112638289A (fr)
AU (1) AU2019292557A1 (fr)
BR (1) BR112021004809A2 (fr)
CA (1) CA3110779A1 (fr)
CR (1) CR20210059A (fr)
EA (1) EA202190494A1 (fr)
WO (1) WO2020006444A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170115A1 (fr) * 1984-07-20 1986-02-05 Kao Corporation Dissolvant de thrombus
WO2007080515A1 (fr) * 2006-01-13 2007-07-19 Aker Biomarine Asa Extrait de krill prevenant la thrombose

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7278094A (en) * 1994-06-07 1996-01-04 M D Serv Europe S.A. Intravasal thrombolysis
US6022309A (en) * 1996-04-24 2000-02-08 The Regents Of The University Of California Opto-acoustic thrombolysis
FR2797768B1 (fr) * 1999-09-01 2003-06-13 Ifremer Utilisation d'un polysaccharide sulfate de bas poids moleculaire pour l'obtention d'un medicament actif contre la thrombose vasculaire
DK1406641T3 (da) * 2001-06-18 2009-05-04 Neptune Technologies & Bioress Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
ES2396964T3 (es) * 2001-10-01 2013-03-01 Matrizyme Pharma Corporation Uso de colagenasa para facilitar el cruce con alambre de guia de oclusiones arteriales crónicas
CN1210036C (zh) * 2002-06-18 2005-07-13 蚌埠丰原医药科技发展有限公司 赖氨匹林的新用途
SE0303588D0 (sv) * 2003-12-30 2003-12-30 Bioactive Polymers Ab C O Lund Surface protection of exposed biological tissues
JP4677557B2 (ja) * 2005-05-11 2011-04-27 国立大学法人東北大学 超音波プローブ及びそれを用いたカテーテル並びにその製造方法
EP1726301A1 (fr) * 2005-05-24 2006-11-29 Flamel Technologies Composition pharmaceutique pour le traitement de maladies transmises par COX-2
DE102005042338B4 (de) * 2005-09-06 2007-07-05 Siemens Ag Kathetereinrichtung
EP2663335A1 (fr) * 2011-01-13 2013-11-20 Medestea Internazionale S.p.A. Composition pour régénérer des tissus atrophiques
US10687832B2 (en) * 2013-11-18 2020-06-23 Koninklijke Philips N.V. Methods and devices for thrombus dispersal
DE202015002060U1 (de) * 2015-03-17 2015-11-25 Gerhard-Friedrich Horak Infusions- und Aspirations- Catheter (IAC) (Katheter zur Entfernung von Thromben und Applikation von Medikamenten)
CN110177527B (zh) * 2016-08-12 2022-02-01 科尼尔赛德生物医学公司 用于调节药剂递送用针的插入深度的装置和方法
EP3554611A1 (fr) * 2016-12-13 2019-10-23 Boston Scientific Scimed Inc. Système de cathéter pour thrombolyse

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170115A1 (fr) * 1984-07-20 1986-02-05 Kao Corporation Dissolvant de thrombus
WO2007080515A1 (fr) * 2006-01-13 2007-07-19 Aker Biomarine Asa Extrait de krill prevenant la thrombose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SJODAHL JOHAN ET AL: "Characterization of proteinases from Antarctic krill (Euphausia superba)", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, vol. 26, no. 1, 1 October 2002 (2002-10-01), pages 153 - 161, XP002359070, ISSN: 1046-5928, DOI: 10.1016/S1046-5928(02)00519-3 *

Also Published As

Publication number Publication date
EP3813687A1 (fr) 2021-05-05
AU2019292557A1 (en) 2021-04-01
JP2022525713A (ja) 2022-05-19
EA202190494A1 (ru) 2021-12-09
CN112638289A (zh) 2021-04-09
BR112021004809A2 (pt) 2021-06-22
CR20210059A (es) 2021-12-23
WO2020006444A1 (fr) 2020-01-02
CA3110779A1 (fr) 2020-01-02

Similar Documents

Publication Publication Date Title
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3840730A4 (fr) Compositions pour l'administration d'agents thérapeutiques et leurs méthodes d'utilisation et leurs procédés de préparation
EP3716767A4 (fr) Méthodes et compositions pour le traitement de maladies rares
IL271807A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
EP3813853A4 (fr) Compositions pour l'administration de médicaments et leurs méthodes d'utilisation
EP3268007A4 (fr) Compositions et procédés thérapeutiques pour le traitement de maladies associées au complément
IL279397A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
EP3672587A4 (fr) Compositions pharmaceutiques destinées au traitement d'affections ophtalmiques
EP3969597A4 (fr) Compositions et procédés pour le traitement de maladies médiées par l'atpase
EP3518918A4 (fr) Méthodes et compositions pharmaceutiques pour le traitement de la stéatohépatite non alcoolique
EP3740592A4 (fr) Méthodes et compositions pour le traitement d'une maladie vasculaire
MX2017010277A (es) Cenicriviroc para el tratamiento de la fibrosis.
EP3600324A4 (fr) Composés et compositions pour le traitement de troubles oculaires
EP3518951A4 (fr) Compositions et méthodes pour le traitement d'affections orthopédiques
EP3716975A4 (fr) Méthodes et compositions pharmaceutiques pour le traitement de la stéatohépatite non alcoolique
EP3468540A4 (fr) Compositions pharmaceutiques et méthodes de traitement du cancer
EP3525787A4 (fr) Méthodes de traitement et compositions pharmaceutiques utilisant bcn057 ou bcn512
EP3322435A4 (fr) Compositions pharmaceutiques utiles pour le traitement de lésions tissulaires
EP3813687A4 (fr) Compositions pharmaceutiques et procédés pour le traitement de la thrombose et l'administration par des dispositifs médicaux
EP3781194A4 (fr) Compositions et méthodes pour l'administration sélective d'agents thérapeutiques et/ou d'imagerie
EP3582787A4 (fr) Préparation pharmaceutique pour la prévention et le traitement de maladies inflammatoires et dégénératives
SI3586832T1 (sl) Farmacevtski sestavek za zdravljenje zaprtja
EP3340985A4 (fr) Compositions pharmaceutiques et procédés de traitement de maladies liées à l'hypoxie
GB201814764D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
EP3813849A4 (fr) Méthodes et compositions pour le traitement de la douleur et/ou de l'inflammation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210128

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40048989

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20220223

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/48 20060101ALI20220217BHEP

Ipc: A61K 38/26 20060101ALI20220217BHEP

Ipc: A61K 31/616 20060101ALI20220217BHEP

Ipc: A61M 25/10 20130101ALI20220217BHEP

Ipc: A61K 38/43 20060101ALI20220217BHEP

Ipc: A61B 17/12 20060101AFI20220217BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MARIZYME, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230822

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230907

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20240103